FDA licenses adverse event prediction tool; NIH inks deal for AI-discovered drug;

> The FDA licensed software to predict safety risks of new products from Molecular Health. Release

> The NIH inked a deal to move one of the drugs discovered by Berg's computer platform through preclinical tests. Article

> HudsonAlpha and Macrogen added 10X Genomics' GemCode to their suites of sequencing tools. News

> Medidata ($MDSO) edged further into China by winning a contract to support Walvax Biotechnology's pediatric vaccine program. More

> Atlas Regeneration, a developer of drug discovery software for regenerative medicines, began operations. Item

> Genomics England began crowdsourcing the creation of a rare disease gene panel. Post

> CDISC established a global standard for biospecimen and genetics-related data. Release

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.